Hepatic Arterial Infusion Chemotherapy Combined Lenvatinib and PD-1 Inhibitor Showed Improved Survival for Infiltrative ...
Introduction Hepatocellular carcinoma (HCC) is the sixth most common malignancy and still ranks the third leading cause of cancer-related death.1 HCC can be divided as nodular and infiltrative types, and the majority comprise the single or multiple nodular …